Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

350MW power connection reserved for HySynergy Phase II

Herning, Denmark, 7 February 2022 - The Danish TSO, Energinet has positively assessed Everfuel’s request for a 350MW power connection for Phase II of the HySynergy power-to-X (PtX) plant in Fredericia, Denmark. Phase I of the 20 MW PtX plant is currently under construction and is planned to be scaled to 300MW by 2025. Moving towards the approval of being able to connect the 350 MW power connection to a nearby 150kV transformer station is a vital step in realising Phase II of the PtX plant. The next step towards getting the approval from Energinet is the so-called pre-construction

Fabege launches share buy-back

Fabege AB (publ) has started the share buy-back programme approved by the Annual General Meeting on 25 March 2021. The AGM authorised the Board for a period no later than the next AGM to acquire Fabege shares. The shares acquired may not exceed 10 per cent of the total number of outstanding Fabege shares at any time.The purpose of the buy-back programme is to enable the Company to continuously adapt its capital requirements and thereby improve shareholder value. The repurchases will be made on the Stockholm Stock Exchange at a price within the registered share price interval on each

First gold mover advantage in Ethiopia

“Our maiden resource estimate done by SRK Consulting indicates 52 000 oz at 20.9 g/t on average, which is fairly astonishing." Mining Review Africa has captured our story and potential in their 1. issue of 2022. Read the original article here.  --- It was a chance meeting between Euronext/Oslo-listed Akobo Minerals’ CEO JØRGEN EVJEN and an Ethiopian businessman in Norway in 2009 that set in motion exploration activities in the East African country.  Jump forward to today and

Correction - Flowscape releases the Q4 report tomorrow

Flowscape’s quarter four report for 2021 will be finalized earlier than planned and will be released tomorrow February 8, 2022.According to the quarter three report, the quarter four report was planned to be released on February 24, 2022. This will now be completed earlier than expected and will thus be released on February 8, 2022. Correction to previous press release: This is not a MAR-rated (EU nr 596/2014) news; therefore, this correction is sent out where the MAR classification has been removed. In other aspects, the press release is identical to previous press release.

Aker ASA: Invitation to Presentation of Q4 2021 Results

Aker ASA will publish its financial results for the fourth quarter of 2021 on Friday February 18, 2022, at 07:00 CET. The company will host a webcast presentation of the results the same day at 09:00 CET.Aker ASA Q4 2021 webcast presentation:Date: Friday February 18, 2022Time: 09:00 a.m. CETFormat: Live webcastLanguage: EnglishLink: Aker ASA Webcast Q4 2021 (royalcast.com)  The Q4 2021 report and presentation will be made available at www.akerasa.com and www.newsweb.no. END This information is subject to

Repurchase own shares

AddLife has today repurchased own shares of 181,000 Class B shares at a price of SEK 189.38 per share. The purchase has been made via Nasdaq Stockholm at the price interval prevailing. The repurchase is carried out in accordance with the Annual General Meeting's authorization to the Board to acquire shares in the Company. The purpose of the repurchase is to cover the Company’s obligations under previously resolved incentive programs and to make possible future acquisitions of companies and businesses with payment in the form of shares in the Company. AddLife AB holds after the

Year-end report 2021

Increased rental income, improved profit from property management and positive changes in value delivered strong earnings in 2021. Net lettings of SEK 162m was one of the best performances ever.· Rental income increased to SEK 2,889m (2,806). In an identical portfolio, rental income rose slightly more than 2 per cent (5).  · Net operating income increased to SEK 2,185m (2,112). In an identical portfolio, net operating income rose by 3 per cent (6). The surplus ratio was 76 per cent (75). · Residential development sales amounted to SEK 62 million and gross profit amounted to SEK -9

SAS AB (publ) announces notice of the annual general meeting on 17 March 2022

Shareholders in SAS AB (publ) (hereinafter the “Company”) are hereby invited to attend the Annual General Meeting on Thursday 17 March 2022. Due to the corona virus, the Board has decided for the Annual General Meeting to be held without physical presence of shareholders, representatives and third parties, and that shareholders shall have the possibility to exercise their voting rights only through advance voting (postal voting) in accordance with the Act on temporary exceptions to facilitate the execution of general meetings in companies and other associations which is expected to enter

The pharmaceutical company Dicot is gearing up for next phase

Press release: Uppsala, February 7, 2022. The pharmaceutical company Dicot strengthens its management ahead of next phase in the company's development. Current VP and COO Elin Trampe is appointed CEO and will succeed current CEO Göran Beijer from April 1, 2022. Björn Petersson takes over as new CFO from March 7, 2022.The pharmaceutical company Dicot develops drugs within sexual dysfunctions with focus on bringing the drug candidate LIB-01 into clinical phase. Dicot will now strengthen and broaden the management team with the objective to take the company to the next phase and focus on

3Shape settles Legal disputes with Align Technology

Copenhagen, February 7, 2022 - 3Shape, a global leader in digital solutions for dentistry, and Align Technology, Inc. have settled the ongoing patent infringement and antitrust legal disputes between the two companies. The terms of the settlement are confidential. Following the settlement, Align will continue its current practice of accepting scans from 3Shape TRIOS 2 and 3Shape TRIOS 3 intraoral scanners in certain jurisdictions outside the United States. Jakob Just-Bomholt, CEO of 3Shape, commented, "I am pleased that we have reached a fair and equitable agreement with Align

M Bilar Group increases heavily their marketing commitment to 3,615,000 SEK with Ampilio for 2022

M Bilar Group increases heavily their marketing commitment to 3,615,000 SEK with Ampilio, a subsidiary of SpectrumOne, for 2022 - a significant increase of over 110% compared to last year's contract.   M Bilar Group sells and serves BMW and MINI, and is one of Sweden's largest BMW dealers in Sweden. They have facilities in Eskilstuna, Västerås, Örebro, and Borlänge. Their earnings development has been through a great trend during the years they have been working with Ampilio. The company has sales reaching approximately SEK 1,4 Billion annually and is seeing an unbroken trend of higher

BioStock: Cyxone about the advancements in the T20K project

Biotech company Cyxone recently announced the next step in the T20K project, their drug candidate for multiple sclerosis. The company has signed an agreement with a renowned European contract development and manufacturing organisation for the scale up and manufacturing of the active ingredient of T20K. BioStock reached out to Cyxone’s CEO Tara Heitner for a comment.Read the interview with Cyxone's CEO Tara Heitner at biostock.se: https://www.biostock.se/en/2022/02/cyxone-on-the-advancements-in-the-t20k-project/ This is a press release from BioStock - Connecting Innovation & Capital.

Students assist in appeal to identify possible murder victim

A fresh appeal to identify a suspected murder victim found nearly three decades ago has launched thanks to new leads uncovered by Staffordshire University students.On 11 July 1994, the body of a middle-aged man believed to be British was recovered by a police boat in the North Sea, West of the Island Heligoland near Germany. The body showed injuries on the head and upper body, and there was evidence of him having been weighted down, suggesting intentional harm. Previous attempts to identify the man dubbed ‘the gentleman’ by German police have been unsuccessful and the case remains open.

Top-class young mathematics researchers recruited to Sweden

Knut and Alice Wallenberg Foundation has allocated SEK 50 million for recruitment of four pre-eminent mathematics researchers to three Swedish universities.“In the prevailing global situation and thanks to the Foundation’s ongoing major mathematics initiative, Sweden has become attractive to leading researchers in mathematics. Combined with the general increasing competitiveness of Swedish mathematics, this has created the potential to recruit top-class researchers to Sweden, making a significant contribution to the development of Swedish research” says Peter Wallenberg Jr, Chair of Knut

Invitation to teleconference/audio transmission

Concordia Maritime welcomes you to participate in a teleconference/audio transmission on February 10, 2022 at 3.00 pm CET.The session will feature a presentation of the Financial Statement for the full year 2021 and a Q&A session. Presiding: Erik Lewenhaupt, CEOMartin Nerfeldt, CFO The teleconference will be available at: SE: +46856642692UK: +443333009265US: +16467224902 To access the audio transmission, please click on the link below: https://tv.streamfabriken.com/concordia-maritime-q4-2021 Questions can be posed verbally via the teleconference, or in writing via

Redwood Pharma receives approval from an Austrian ethics committee for start of a clinical trial of RP501

Redwood Pharma has received approval from an Austrian ethics committee for the start of a clinical trial of RP501. This application represents the first of two necessary approvals for the commencement of the clinical trial. The company will now submit the clinical trial application for national approval by the Austrian Federal Office for Safety in Health Care (BASG). This initiates Redwood Pharma’s development efforts towards a CE-marking approval of RP501, the company’s novel, first-line treatment for relief of dry eye disease (DED). A CE-marking approval will facilitate the future sale of

61 percent of Inwido's sales 2021 met the Taxonomy's screening criteria

When Inwido sums up the 2021 sales of windows and doors via the Group's 29 business units, 61 percent of the sales reach the screening criteria in the taxonomy to make a substantial contribution, which are stated at a u-value of 1.0 for windows and 1.2 for doors. The share is a significant step forward compared to a share of 45 percent for the 2020 financial year.The European Commission's limit values aim to steer investments towards the use of modern windows and doors, which are significantly more energy-saving than older products that are to a very large extent found in today's buildings

SAS Traffic figures - January 2022

Ramp-up was slowed down by Omicron in JanuaryIn January 760,000 passengers traveled with SAS, an increase of 170% compared to the same month last year. SAS’ capacity also increased by approximately 170% compared with the same period last year. In comparison with last month, the total number of passengers decreased with almost 25% and capacity was reduced by almost 10%. The flown load factor for January was 49%, an improvement of 19 percentage points compared to January last year. “It will come as no surprise that Omicron had an impact on customer demand during the month, with additional

Webcast with Teleconference, Q4 / 2021

Nitro Games to host a Webcast with Teleconference on Monday 14 February 2022 09:30 Swedish time.Nitro Games Oyj Year-End Report for January - December 2021 will be released on Monday 14 February 2022. The Company will do a presentation after the release of the report. Participants can join this presentation by a Webcast or Teleconference. Participants can send questions to the presenters via email below. 14 February 2022 09:30 (Europe/Stockholm) Details of event: https://financialhearings.com/event/13859 Language: English Activity: Webcast with Teleconference Webcast: https://

ContextVision confirms the value of the upcoming dividend

Stockholm, February 7[th], 2022, in accordance with the regulations of the Oslo Stock Exchange. ContextVision hereby confirms the value of the upcoming dividend. In accordance with the information in the notice to the Extraordinary General Meeting published on November 15, 2021, the company confirms that the value of the dividend distribution in form of the shares in Inify Laboratories AB is equal to the book value of the relevant assets in ContextVision and amounts to SEK 31,753,090. This represents a distribution of SEK 0.41 per share held in ContextVision. https://www.

OssDsign steps up ambition to generate further clinical evidence for its bone replacement products through key recruitment

Uppsala, February 7, 2022. OssDsign AB (publ.) today announces that Melanie Marshall has been recruited to a new position as Vice President Clinical & Medical Affairs. This is an important step in the strategic ambition to accelerate data collection and publication of clinical evidence for the company’s innovative bone replacement products, OssDsign Cranial PSI and OssDsign Catalyst. Melanie Marshall has a wealth of experience from senior positions at global medtech companies, such as Boston Scientific, Apatech/Baxter and Medtronic.The creation of a new senior position with responsibility

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 33 - 7 FEBRUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

DAMPSKIBSSELSKABET NORDEN A/S – WEEKLY REPORT ON SHARE BUY-BACK

ANNOUNCEMENT NO. 32 - 7 FEBRUARY 2022 On 4 November 2021, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2021 up to and including no later than end February 2022. For details, please see announcement no. 75 of 4 November 2021. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 40 million (approximately DKK 263 million).

There are no items matching the current filter
There are no more items matching the current filter
Back to top